Conyers Dill & Pearman is providing Cayman law advice to New WuXi Life Science Ltd. in connection with a $3.3bn buyout of WuXi PharmaTech Inc., a US-listed Chinese company, which is expected to close in Q4 of 2015.

David Lamb, of Conyers’ Hong Kong office, is advising on the matter, working alongside Wilson Sonsini Goodrich & Rosati, Sullivan & Cromwell, Weil Gotshal & Manges and Fangda Partners.